biological_process

INFLAMMASOME

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about INFLAMMASOME: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1935Connections

22Hypotheses

0Analyses

50Outgoing

50Incoming

10Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🧬 Biological Process Info

Name	INFLAMMASOME
Key Genes/Proteins	ABCA1, ACHE, AD, AKT, AMPK, AMYLOID-BETA
Related Diseases	Alzheimer's Disease, ALZHEIMER'S DISEASE, ANXIETY
Related Pathways	APOPTOSIS

Pathway Diagram

graph TD
    INFLAMMASOME["Inflammasome"]
    NLRP3["NLRP3"]
    PYCARD["PYCARD/ASC"]
    MICROGLIA["Microglia"]
    INFLAMMATION["Inflammation"]
    TNF["TNF-alpha"]
    IL1B["IL-1beta"]
    NEURODEGENERATION["Neurodegeneration"]
    PARKINSON["Parkinson's Disease"]
    MULTIPLE_SCLEROSIS["Multiple Sclerosis"]
    SNCA["alpha-synuclein (SNCA)"]
    PARKIN["Parkin"]
    AUTOPHAGY["Autophagy"]
    UBIQUITIN["Ubiquitin System"]

    NLRP3 -->|"forms"| INFLAMMASOME
    PYCARD -->|"assembles"| INFLAMMASOME
    INFLAMMASOME -->|"activates"| MICROGLIA
    INFLAMMASOME -->|"triggers"| INFLAMMATION
    INFLAMMASOME -->|"releases"| TNF
    INFLAMMASOME -->|"releases"| IL1B
    INFLAMMATION -->|"promotes"| NEURODEGENERATION
    MICROGLIA -->|"amplifies"| INFLAMMATION
    SNCA -->|"activates"| INFLAMMASOME
    NEURODEGENERATION -->|"leads to"| PARKINSON
    NEURODEGENERATION -->|"contributes to"| MULTIPLE_SCLEROSIS
    INFLAMMASOME -->|"impairs"| AUTOPHAGY
    PARKIN -->|"regulates"| AUTOPHAGY
    AUTOPHAGY -->|"clears"| SNCA
    INFLAMMASOME -->|"activates"| UBIQUITIN

    style INFLAMMASOME fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0
    style AUTOPHAGY fill:#1b5e20,stroke:#333,stroke-width:2px
    style PARKIN fill:#1b5e20,stroke:#333,stroke-width:2px
    style NEURODEGENERATION fill:#ef5350,stroke:#333,stroke-width:2px
    style INFLAMMATION fill:#ef5350,stroke:#333,stroke-width:2px
    style PARKINSON fill:#7d4200,stroke:#333,stroke-width:2px
    style MULTIPLE_SCLEROSIS fill:#7d4200,stroke:#333,stroke-width:2px
    style NLRP3 fill:#4a1a6b,stroke:#333,stroke-width:2px
    style SNCA fill:#4a1a6b,stroke:#333,stroke-width:2px
    style TNF fill:#4a1a6b,stroke:#333,stroke-width:2px

Outgoing (428)

Target	Relation	Type	Str
ALS	contributes_to	disease	0.95
ALZHEIMER'S DISEASE	associated_with	disease	0.95
Microglia	activates	cell_type	0.95
Microglial M1 Polarization	causes	phenotype	0.95
PARKINSON'S DISEASE	contributes_to	disease	0.95
Neurodegeneration	promotes	process	0.95
Neuroinflammation	activates	process	0.95
M1 Polarization	causes	phenotype	0.95
Oxidative Phosphorylation	downregulates	pathway	0.95
Glycolysis	upregulates	pathway	0.95
DEMENTIA	contributes_to	disease	0.92
Misfolded Protein Aggregation	associated_with	process	0.90
Dopaminergic Neurodegeneration	mediates	process	0.90
Metabolic Reprogramming	causes	process	0.90
NEUROINFLAMMATION	mediates	process	0.89
Protein Aggregation	associated_with	process	0.88
M1 Polarization	causes	phenotype	0.88
MICROGLIA	interacts_with	cell_type	0.86
AUTOPHAGY	activates	process	0.86
Multiple Sclerosis	involved_in	disease	0.85
Alzheimer's Disease	involved_in	disease	0.85
Parkinson's Disease	involved_in	disease	0.85
Oxidative Phosphorylation	inhibits	process	0.85
Alzheimer Disease	associated_with	disease	0.85
organ fibrosis	drives	disease	0.85
Parkinson Disease	associated_with	disease	0.85
pyroptosis	activates	phenotype	0.64
LRP1	interacts_with	gene	0.60
MTOR	enhances	gene	0.60
NLRP3	interacts_with	gene	0.60
microglia	activates	entity	0.60
PYROPTOSIS	regulates	pathway	0.60
NEURONS	activates	cell_type	0.60
NLRP3	disrupts	gene	0.60
MICROGLIA	enhances	cell_type	0.60
NLRP3	enhances	gene	0.60
NEUROINFLAMMATION	causes	pathway	0.60
NLRP3	regulates	gene	0.60
TNF	activates	gene	0.60
PD	co_discussed	gene	0.60
IL1B	activates	protein	0.60
STING	regulates	gene	0.60
SMPD1	activates	gene	0.60
TNF	expressed_in	gene	0.60
NLRP3	activates	gene	0.60
PD	activates	gene	0.60
NLRP3	inhibits	gene	0.60
MICROGLIA	expressed_in	cell_type	0.60
MITOPHAGY	activates	pathway	0.60
NLRP3	causes	gene	0.60

Incoming (1507)

Source	Relation	Type	Str
Als	regulates	disease	1.00
Alzheimer	activates	disease	1.00
Aging	activates	disease	1.00
INFLAMMATION	regulates	gene	1.00
MITOCHONDRIA	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
INFLAMMATION	inhibits	gene	1.00
MITOCHONDRIAL DYSFUNCTION	activates	gene	1.00
NF-ΚB	activates	gene	1.00
ASC	activates	gene	1.00
IL-6	inhibits	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
DNA	activates	gene	1.00
INFLAMMATION	activates	gene	1.00
NLRP3	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
AIM2	activates	gene	1.00
Als	activates	disease	1.00
MITOPHAGY	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
ROS	activates	gene	1.00
TNF	activates	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
AUTOPHAGY	regulates	gene	1.00
Inflammation	activates	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
AUTOPHAGY	activates	gene	1.00
Neuroinflammation	activates	disease	1.00
Inflammation	inhibits	disease	1.00
MICROGLIA	activates	gene	1.00
Als	therapeutic_target	disease	1.00
PYROPTOSIS	activates	gene	1.00
INFLAMMATION	associated_with	gene	1.00
Inflammation	associated_with	disease	1.00
CYTOKINES	activates	gene	1.00
Atherosclerosis	activates	disease	1.00
UBIQUITIN	activates	gene	1.00
Infection	activates	disease	1.00
NLRP3	activates	gene	1.00
Inflammation	regulates	disease	1.00
NLRP3	inhibits	gene	1.00
Neurodegeneration	activates	disease	1.00
PINK1	activates	gene	1.00
PARKIN	activates	gene	1.00
IL-6	activates	gene	1.00
NEURODEGENERATION	activates	gene	1.00
CANCER	activates	gene	1.00
Cancer	activates	disease	1.00
AMYLOID	activates	gene	1.00
NLRP3	involved_in	protein	0.95

Targeting Hypotheses (22)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S	0.822	neurodegeneration	What are the mechanisms by which gut mic
Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in N	0.805	neurodegeneration	What are the mechanisms by which gut mic
Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Re	0.804	neurodegeneration	What are the mechanisms by which gut mic
Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu	0.803	neurodegeneration	What are the mechanisms by which gut mic

microglial inflammasome tone defines the therapeutic window	0.723	neurodegeneration	How does gut microbiome dysbiosis contri
NLRP3 Inflammasome Lock Perpetuates Senescence-Associated In	0.720	neurodegeneration	What molecular mechanisms drive microgli
TREM2 haploinsufficiency dysregulates microglial synaptic su	0.700	neurodegeneration	Synaptic pruning by microglia in neurode
Microbial Inflammasome Priming Prevention	0.653	neurodegeneration	What are the mechanisms by which gut mic
Galectin-3 deletion attenuates NLRP3 inflammasome activation	0.650	neuroscience	Lysosomal dysfunction and cathepsin leak
C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macropha	0.640	neuroinflammation	What are the specific molecular mechanis
NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosi	0.620	neurodegeneration	How does gut microbiome dysbiosis contri
Selective cathepsin B inhibition prevents cathepsin leakage-	0.620	neuroscience	Lysosomal dysfunction and cathepsin leak
LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasom	0.617	neurodegeneration	How do perivascular cells specifically r
Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP	0.590	neurodegeneration	What are the optimal oxygen pressure, du
NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumul	0.566	developmental neurobiology	Do perinatal immune challenges create pe
NLRP3 Inflammasome Blockade as Upstream Intervention to Prev	0.566	neurodegeneration	Why have numerous phase 3 clinical trial
P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming	0.560	biomarkers	What biomarkers can reliably detect micr
TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inf	0.485	Neuroinflammation	Immune atlas neuroinflammation analysis
Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling	0.453	neuroinflammation	What molecular mechanisms mediate SPP1-i
Sub-antidepressant Doses Suppress NLRP3 Inflammasome via P2X	0.440	-	What is the minimum effective dose of tr
NLRP3 Inflammasome Suppression via Selective Caspase-1 Inhib	0.105	neurodegeneration	Neuroinflammation Biomarker Panel for Ea

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (10)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiation Mechanis	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Antiviral Therapy Trial for Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Experiment: Autoimmune Hypothesis Testing in AD	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Microbiome-Gut Barrier Signatures in ALS — Experiment Design	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism and inter	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$7,500,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Regulated Necrosis Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990]	["Di Q", "Zhao X", "Tang H", "Li X", "Xi	Autophagy	2023	1
USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradatio [PMID:34486483]	["Cai B", "Zhao J", "Zhang Y", "Liu Y",	Autophagy	2022	1
Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861]	["Han X", "Sun S", "Sun Y", "Song Q", "Z	Autophagy	2020	1
Interweaving microglial senescence and gut microbiome dynamics in Alzheimer's di [PMID:41747877]	Waghmare A, Rahangdale S, Khare K, Taksa	Molecular and cellular neurosc	2026	0
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peri [PMID:41569436]	Gopalakrishna PK, Che Mohd Nassir CMN, A	Cellular and molecular neurobi	2026	0
Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter [PMID:41687275]	Otálora-Alcaraz A, Sun MC, Hofman N, Cos	Multiple sclerosis and related	2026	0
NLRP3 Inflammasome and Polycystic Ovary Syndrome (PCOS): A Novel Profile in Adip [PMID:41596350]	Alenezi SA, Alshammari K, Khan R, Amer S	International journal of molec	2026	0
Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP- [PMID:40958035]	Li Z, Sun X, Wang Y	Basic Res Cardiol	2025	0
Exploring the Role of Microglial Cells in the Gut-Brain Axis Communication: A Sy [PMID:40662222]	Ortiz-Samur NS, Vijaya AK, Burokas A, Me	Journal of neurochemistry	2025	0
Sepsis and the Liver. [PMID:41439929]	["Geladari E", "Kalergi A", "Evangelopou	Diseases (Basel, Switzerland)	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	Int J Mol Sci	2025	0
Molecular links between inflammatory bowel disease and Alzheimer's disease throu [PMID:41480321]	Durairajan SSK, Singh AK, Sulaiman SM, P	World journal of gastroenterol	2025	0
Bone marrow vacuolization to curative strategies: Evolving paradigms in VEXAS sy [PMID:40784090]	["Elbadry M", "Mabed M"]	Current research in translatio	2025	0
Δ9-Tetrahydrocannabinol and cannabidiol selectively suppress toll-like receptor [PMID:40553974]	Sermet S, Finn BM, Crawford RB, Kaminski	The Journal of pharmacology an	2025	0
Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346]	Borim PA, Gatto M, Mota GAF, Meirelles A	International journal of molec	2025	0
Joint-specific memory, resident memory T cells and the rolling window of opportu [PMID:38600215]	Chang MH, Fuhlbrigge RC, Nigrovic PA	Nat Rev Rheumatol	2024	0
The NLRP3-inflammasome inhibitor MCC950 improves cardiac function in a HFpEF mou [PMID:39616735]	["Li S", "Withaar C", "Rodrigues P", "Zi	Biomedicine & pharmacotherapy	2024	0
Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation [PMID:38808326]	Yu Y, Miao TW, Xiao W, Mao B, Du LY, Wan	Drug design, development and t	2024	0
Inhibition of autophagy in microglia and macrophages exacerbates innate immune r [PMID:36652438]	Hegdekar N, Sarkar C, Bustos S, Ritzel R	Autophagy	2023	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning INFLAMMASOME in their description or question text

microglial inflammasome tone defines the therapeutic window for: How does gut mi

Score: 0.723 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing microglial inflammasome tone with dietary fiber chall

NLRP3 Inflammasome Lock Perpetuates Senescence-Associated Inflammasome Phenotype

Score: 0.720 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome represen

TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switchin

Score: 0.700 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The triggering receptor expressed on myeloid cells 2 (TREM2) functions as a criti

Microbial Inflammasome Priming Prevention

Score: 0.653 · neurodegeneration · 2026-04-02

Pathogenic gut bacteria prime peripheral macrophages through NLRP3 inflammasome activation, creating a systemic pro-infl

Galectin-3 deletion attenuates NLRP3 inflammasome activation downstream of lysos

Score: 0.650 · neuroscience · 2026-04-22

**Molecular Mechanism and Rationale** Galectin-3 (LGALS3) functions as a critical molecular sensor and platform orchest

C1Q-Triggered NLRP3 Inflammasome Assembly in Plaque Macrophages

Score: 0.640 · neuroinflammation · 2026-04-21

**Molecular Mechanism and Rationale** The C1Q complement system component represents a critical bridge between innate i

NLRP3 Inflammasome Priming Converts SCFA-Sensitive Pyroptosis into Chronic IL-1β

Score: 0.620 · neurodegeneration · 2026-04-26

Gut-derived bacterial components (LPS, MDP) provide Signal 1 for NLRP3 inflammasome priming via TLR4/TLR2/NOD2, inducing

Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 infla

Score: 0.620 · neuroscience · 2026-04-22

## Mechanistic Overview Selective cathepsin B inhibition prevents cathepsin leakage-mediated NLRP3 inflammasome activati

LRP1/NLRP3/IL-1β Cascade Links Aβ Endocytosis to Inflammasome Activation and SPP

Score: 0.617 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The proposed LRP1/NLRP3/IL-1β cascade represents a critical mechanistic link betw

Intermittent HBOT (2.0 ATA, 60 min, 3x/week) suppresses NLRP3 inflammasome and s

Score: 0.590 · neurodegeneration · 2026-04-25

This hypothesis proposes that HBOT reduces ROS-mediated NF-κB activation and NLRP3 inflammasome assembly, promoting anti

NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation

Score: 0.566 · developmental neurobiology · 2026-04-21

## Mechanistic Overview NLRP3 Inflammasome Chromatin Priming Through H3K27ac Accumulation starts from the claim that mod

NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplificati

Score: 0.566 · neurodegeneration · 2026-04-16

## Mechanistic Overview NLRP3 Inflammasome Blockade as Upstream Intervention to Prevent SASP Amplification starts from t

P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming

Score: 0.560 · biomarkers · 2026-04-22

## Mechanistic Overview P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming starts from the claim that modulatin

TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation

Score: 0.485 · Neuroinflammation · 2026-04-21

## Mechanistic Overview TFEB-Mediated Lysosomal Biogenesis Enhancement for NLRP3 Inflammasome Regulation starts from the

Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling

Score: 0.453 · neuroinflammation · 2026-04-21

## Mechanistic Overview Mitochondrial Damage-Triggered SPP1 Inflammasome Coupling starts from the claim that modulating